Gross Profit Trends Compared: Teva Pharmaceutical Industries Limited vs Arrowhead Pharmaceuticals, Inc.

Pharma Giants' Profit Trends: A Decade in Review

__timestampArrowhead Pharmaceuticals, Inc.Teva Pharmaceutical Industries Limited
Wednesday, January 1, 201417500011056000000
Thursday, January 1, 201538200011356000000
Friday, January 1, 201615833311859000000
Sunday, January 1, 20173140770910825000000
Monday, January 1, 2018161423218296000000
Tuesday, January 1, 20191687955777536000000
Wednesday, January 1, 2020879920667725000000
Friday, January 1, 20211382870007594000000
Saturday, January 1, 20222328100006973000000
Sunday, January 1, 20232407350007646000000
Monday, January 1, 202435510008064000000
Loading chart...

Unleashing the power of data

A Tale of Two Pharmaceuticals: Gross Profit Trends

In the ever-evolving pharmaceutical industry, understanding financial trends is crucial. This analysis compares the gross profit trajectories of Teva Pharmaceutical Industries Limited and Arrowhead Pharmaceuticals, Inc. from 2014 to 2023. Teva, a global leader, consistently reported robust profits, peaking in 2016 with a 7% increase from the previous year. However, a downward trend followed, with a 41% decline by 2022. In contrast, Arrowhead, a smaller player, showed remarkable growth. From a modest start in 2014, its gross profit surged by over 1,300% by 2023, highlighting its dynamic expansion. Notably, data for 2024 is incomplete, reflecting the unpredictable nature of the market. This comparison underscores the diverse strategies and market positions of these companies, offering valuable insights for investors and industry analysts alike.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025